| C27 | Assessing the cost of PrEP delivery in Mexico: results from the ImPrEP study | E-poster | PrEP |
| C27 | Importance of accounting for ART costs saved in the long term when estimating HIV pre-exposure prophylaxis (PrEP) cost-effectiveness: a modeling study informed by the ImPrEP demonstration project | E-poster | PrEP |
| C27 | Low PrEP uptake among gay, bisexual, and other men who have sex with men in five Asian countries: results of the Asia Pacific MSM Internet Survey | E-poster | PrEP |
| C27 | HIV recent infection test-based incidence as a counter-factual for new PrEP trials | E-poster | PrEP |
| C27 | Effectiveness and medication adherence of daily and event-driven pre-exposure prophylaxis regimens among Chinese men who have sex with men: a real-world CROPrEP study | E-poster | PrEP |
| C27 | Long-acting capsid inhibitor effective as PrEP against vaginal SHIV transmission in macaques | E-poster | PrEP |
| C27 | Long-acting injectable PrEP in women: laboratory analysis of HIV infections in HPTN 084 | E-poster | PrEP |
| C41 | Motivations and concerns regarding PrEP use during pregnancy: associations with decisional regret and one-month PrEP adherence among pregnant women in Lilongwe, Malawi | E-poster | PrEP and pregnant women |
| C41 | Transitioning integrated antenatal PrEP delivery from research projects to routine clinic staff at 16 clinics in Western Kenya | E-poster | PrEP and pregnant women |
| C41 | No association between prenatal PrEP exposure and adverse growth outcomes among Kenyan infants: a prospective study | E-poster | PrEP and pregnant women |